Table 1.
Fecal metagenomic studies included in this meta-analysis
| Cohorts | No.of cases | No.of controls | Accession |
|---|---|---|---|
| Discovery cohorts Austria(AUT) |
46 | 63 | ERP008729 |
| Italy(ITA) | 32 | 28 | SRP136711 |
| Japan(JPN) | 40 | 40 | DRA006684 |
| External validation cohorts#1 | |||
| China(CHN) | 8 | 12 | PRJNA663646 |
| Sampling validation cohorts#2 | |||
| Sampling cohort 1 | 44 | 56 | - |
| Sampling cohort 2 | 46 | 54 | - |
| Sampling cohort 3 | 48 | 52 | - |
| Disease comparison cohorts | |||
| IBD-UC | 30 | - | PRJNA400072 |
| IBD-CD | 30 | - | PRJNA400072 |
| Type 2 diabetes(T2D) | 30 | - | PRJNA422434 |
| Liver cirrhosis(LC) | 30 | - | PRJEB6337 |
#1: The data for external validation cohorts has not been published.
#2: The sampling validation cohorts refer to the random sampling of 100 samples from discovery cohorts.